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1.Introduction
One of the main objectives of the EU's 
growth strategy for the coming decade is to 
support the creation and growth of 
innovative companies. Indeed, two of the 
five targets of the Europe 2020 strategy are 
to raise the employment rate of the 
population and to foster innovation by 
raising investment in R&D to 3% of GDP at 
least. Innovative companies, in fact, are 
assumed to play an important role in 
generating economic growth and 
employment. In addition, promoting their 
number and growth is expected to support 
the renewal of the EU economy by shifting 
the industrial sector's composition towards 
more knowledge-intensive activitie1. Among 
innovative companies, R&D performing 
SMEs are a dynamic sub-group expected to 
greatly contribute to economic growth and 
job creation in the EU. 
In the context of Europe’s capacity to hit the 
3% R&D intensity target in 2020, one 
                                                        
Note: Whereas it applies across the document, the sign ’‣' 
indicates that the work is authored/co-authored by JRC-
IPTS staff. 
1  Moncada-Paternò-Castello et al., 2010 ‣ 
important question arises: To what extent 
can faster growth of innovative R&D-
intensive SMEs drive the envisaged 
structural change of the EU economy 
towards high R&D intensive sectors? 2 
Answering this question is important to put 
into perspective the European research and 
innovation agenda’s current policy emphasis 
on supporting higher growth of innovative 
companies.  
This Policy Brief aims to contribute to the 
debate about how to set the right priorities 
and find the most appropriate policy 
interventions to allow Europe to reach the 
3% R&D intensity target and hence its 
growth and employment objectives. It will 
first summarise stylised findings from the 
literature on the relevance of innovative 
companies for economic growth, then 
present results from a recent JRC-IPTS 
study which go some way towards 
answering the question posed above, and 
conclude by outlining some of the 
contributions that enrich the policy debate.  
                                                        
2  The main sectors giving rise to the gap are: ICT, 
Pharmaceuticals & Biotechnology and Health- related. 
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2. Background - What the 
literature says 
Why do firms' R&D and innovation 
matter? Economic theory points to 
technical change as the major source of 
productivity growth in the long run (Solow, 
1957). R&D is thus seen as the major 
driving force for technical change (Romer, 
1990; Guellec and van Pottelsberghe de la 
Potterie, 2001). Both together are 
recognised as key elements for increasing 
any economy’s knowledge base and, with it, 
its growth, productivity and competitiveness 
(Coccia, 2008; Mowery and Rosenberg, 
1989). According to the literature, R&D 
performing / innovative firms are important 
due to their contribution to the following 
fundamental aspects: 
(i) Employment creation: Comparative 
studies on the impact of corporate R&D 
investment on employment have 
demonstrated that an increase in R&D 
expenditure by 1% stimulates employment 
in the business sector by about 0.15% (see 
Bogliaccino et al., 2012 ‣). This result is 
robust and consistent with empirical 
evidence from country level studies. 
However, while the mentioned positive 
impact of R&D expenditures on employment 
figures can generally be confirmed for the 
high-tech sector and services, it is not 
significant in traditional manufacturing.  
(ii) Firms’ competitiveness: Evidence 
suggests that innovating firms are both 
more profitable and grow faster than non-
innovators (Freel, 2000; Geroski and Machin, 
1992). Moreover, Kumbhakar et al. (2012) 
pointed out that there is a positive 
correlation between firms' R&D investment 
and productivity – driven by both 
technological progress and higher technical 
efficiency – which was found to be 
particularly acute in high-tech sectors. 
Accordingly, engaging in R&D activities – via 
technological advancement and by reducing 
inefficiency and waste – helps to increase 
productivity and thus ensures 
competitiveness. 
(iii) Structural changes: The literature on the 
dynamics of industrial structures and the 
growth of innovative companies indicates 
that the EU’s economy has a rather static 
structure which has hardly changed over the 
recent decades and, moreover, it is less 
knowledge-intensive than its main 
competing regions (i.e. Europe is rather 
specialised on medium than on highly 
knowledge-intensive sectors; see Moncada-
Paternò-Castello and Cincera, 2012‣).  
 
Why are innovative SMEs relevant?3 
Recent literature (Cincera and Veugelers, 
2012‣; Czarnitzki and Delanote, 2012; 
Ciriaci et al., 2013‣) unambiguously 
indicates that young innovative companies 
tend to grow more than other firms and that 
the fast-growing, smaller/younger 
innovative firms can play a fundamental 
role for the EU’s economic performance and 
presumably help to accelerate the renewal 
of the industrial structure in the EU. 
However, although about one third of EU 
business expenditures on R&D are made by 
firms with less than 500 employees, 
compared to the US, Europe is lagging 
behind in mere numbers of such R&D-
investing companies of a comparably small 
size.4  
Further relevant literature points to the 
following stylised facts: a) smaller firms 
tend to produce higher-quality innovations, 
b) optimal size-dependent R&D subsidy 
policies generally perform better than size-
independent policies; and c) supporting 
small firms' investment in R&D is often 
more growth-enhancing than subsidising 
large firms (Symeonidis, 1996; Akcigit, 
2009; Coad and Hölzl, 2010; Moncada-
Paternò-Castello, 2011‣). 
3. New facts / new findings from a 
JRC-IPTS simulation exercise 
Rationale and questions 
The current understanding of small firms' 
growth and what policy can contribute in 
this regard relies widely on incomplete 
information, focusing mostly on data 
aggregated at the national and/or industry 
level or on certain variables assumed to 
determine growth (e.g. R&D, tax regimes, 
constraints in terms of factor endowments). 
                                                        
3  See also Annex 
4  In fact, evidence suggests that the average size of R&D 
intensive firms can explain the overall R&D intensity gap 
between the EU and the US. Such kinds of US companies 
are concentrated in sectors that are intrinsically R&D-
intensive, thus raising the US’s overall R&D performance 
vis-à-vis the EU (Moncada-Paternò-Castello et al., 2010 ‣; 
Ortega-Argilés and Brandsma, 2010 ‣). 
3  
 
In this light, a recent JRC-IPTS study (Voigt 
and Moncada-Paternò-Castello, 2012‣) 
addressed the following questions: How 
would the sector composition and the 
overall volume of R&D investment in Europe 
differ in the year 2020 compared to the 
figures from 2010 if the existing top R&D-
investing SMEs were assumed to be on a 
fast growth track while the top R&D-
investing large scale companies continue to 
grow as before? And hence, to what extent 
would accelerated growth of these 
innovative SMEs help to reach the EU R&D 
intensity target set for 2020? 
Methodological approach 
Empirically, the aforementioned JRC-IPTS 
study relied on the sample of top R&D-
investing firms as provided by the EU 
Industrial R&D Investment Scoreboard [SB] 
(containing data of 1,000 EU and 1,000 
non-EU based firms) in the 2010 edition. 
Firm-level data correspond to accounting 
year 2009, which is taken as the starting 
point for individual firm-level projections of 
steady growth paths over a period of 10 
years, thus simulating the SB for 2020 [SB-
2020].  
To calculate the firms’ future growth 
trajectories, the study supplemented data 
from SB-2010 with data from earlier SB 
waves, thus going back as far as 
observations from 2002 (i.e. pooled SB 
data) - altogether 133 EU SMEs were found 
-, constituting an imbalanced panel used for 
the purpose of simulation.  
The firm's growth paths are subject to some 
basic (non-trivial) assumptions: all 
companies in the sample will grow with the 
same rate in terms of employment and 
sales, while the company-level R&D 
intensity (R&D/sales) is assumed to remain 
constant. Scenarios are distinguished for 
SMEs vs. large-scale companies (assumed 
growth paths) and with regard to high-, 
medium- and low-tech industries. Three 
growth scenarios were developedand 
empirically benchmarked vis-à-vis the 
reference scenario as outlined in Table 15  
(next page). 
                                                        
5  Note: Computing a scenario of 5% annual growth of small 
companies was rejected as it would be much lower than 
their current growth path (and even be lower than the 
reference scenario assuming an equal growth rate of 7.1% 
In order to illustrate the BERD/GDP ratio 
(R&D intensity) of the simulated scenarios, 
an average annual GDP growth rate had to 
be assumed for the years 2010 – 2020 
(resulting in a total GDP multiplier). 
Although per year growth rates may 
fluctuate quite substantially, over a longer 
period the assumption of the following three 
scenarios appeared reasonable: mean 
annual GDP growth 2%, 2.5% and 3%. The 
share of EU SB R&D investment to EU BERD 
(86% in 2009) is assumed to remain 
invariant, and the annual BERD growth is 
determined by the assumed overall SB 
annual R&D investment growth in the 
different scenarios. 
The growth hypothesis of the different 
scenarios assumes non-cyclical R&D 
investment behaviour. Empirical evidence in 
this regard (European Commission, 2012‣) 
suggests that top R&D investors keep the 
growth rates of R&D investments well 
above GDP growth rates and, moreover, 
apart from 2009 (which is seen as the peak 
of the financial crisis) their R&D investment 
behaviour has been rather counter-cyclical; 
i.e. raising spending on R&D during the 
recession (ref.: 2010, 2011 figures), which 
gave cause to consider rather high-growth 
scenario projections for the period 2010 – 
2020 (see especially scenarios (B) and (C) in 
Table 1).  
A linear prediction model (according to 
Makhoul, 1975) has been applied to 
simulate the scenarios. The limitations of 
this study appear to be centred in the non-
trivial assumptions with regard to the 
growth scenarios and a rather simplistic 
(linear) projection method, which is due to 
neglect of a number of other factors that 
are relevant to firm and sector dynamics.6  
Results 
Figure 1, in the next page, presents the 
corporate R&D investment shares by sector 
group in the EU in 2010 and outlines the 
simulated EU R&D scoreboard for the year 
2020 according to the reference scenario 
(R-S). 
                                                                              
employment CAGR 8 yrs across all EU companies; thus 
disregarding firm size).  
6  For more details on the methodological approach, see the 
corresponding study by Voigt and Moncada-Paternò-
Castello, 2012‣ 
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Figure 2, in the next page, illustrates the results of the projected EU Industrial R&D Investment 
Scoreboard for 2020 (target scenarios A, B and C). 
 
Table 1. Scenarios of growth rates and corresponding EU firms’ R&D investment in2002 
Scenarios Annual growth rates 
Resulting total EU firms' R&D 
investment in 2020              
(in constant 2010 €billion) 
Reference Scenario R-S           
(status quo growth path) 
7.1% regardless of firm size 227 
Target Scenario A SMEs: 10% Large: 5.8% 221 
Target Scenario B SMEs: 20% Large: 5.8% 228 
Target Scenario C SMEs: 30% 
Large: 5.8% 244 
Source: Voigt and Moncada-Paternò-Castello, 2012‣ 
Note: More details about the scenarios are provided in the Annex. 
Figure 1.  Corporate R&D investment shares by sector group in EU-27 (left side) in 2010            
and as an assumed reference scenario (R-S) for 2020 (right hand side) 
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Source:  The 2010 EU Industrial R&D Investment Scoreboard, European Commission, JRC/DG RTD and own 
calculations 
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Figure 2. Projected EU Industrial R&D Investment Scoreboard for 2020 –  
 R&D investment shares by sector group - Scenario results 
 
 
 
 S-A: 10% p.a. growth for SMEs until 2020  
 
Compared to SB 2010: 
S-A suggests that high-tech sectors  
(especially Pharmaceuticals & Biotech) as  
well as low-tech industries may increase  
their sectoral shares on overall R&D  
investment in EU-27; medium-tech  
sectors (esp. Automotive & Parts) tend to 
decrease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Legend:  Black: high-tech. Dark grey: medium-high tech. Lighter grey: medium-low tech. White: low-tech 
 
Source: JRC-IPTS (2012 ‣) calculations based on data from the 2010 EU Industrial R&D Investment Scoreboard 
(European Commission, JRC/DG RTD, 2011‣)  
 
Note:  Table A1 in the Annex provides more detailed information concerning the results of the scenario projections 
broken up by sector groups and in monetary figures.  
S-B: 20% p.a. growth for SMEs until 2020 
 
Compared to SB 2010: 
According to S-B, the assumed fast growth 
track of small firms is expected to lead to a 
moderate shift in terms of shares on overall 
R&D investments in EU-27 from medium 
towards high-tech sectors (thus underlining 
the importance of small firms, particularly for 
Pharmaceuticals & Biotech sector). 
Nevertheless, the magnitude of the increase in 
R&D investments remains relatively small 
given the assumed fast growth scenario of 
20% p.a. (R&D growth +3% compared to S-A) 
S-C: 30% p.a. growth for SMEs until 2020 
 
Compared to SB 2010: 
S-C represents the most optimistic growth 
scenario. In fact, the simulated R&D 
investments for the year 2020 are 90% above 
the figures of SB 2010 with the most significant 
increase expected for high-tech sectors 
(+140%). In contrast, the importance of 
medium-tech sectors for corporate R&D in 
Europe seems to be decreasing.  
 
Nevertheless, the scenario illustrates that even 
under the assumption of extreme growth in 
small R&D-intensive companies over a 
comparably long period (as assumed in S-C), 
the sector composition of business R&D in 
Europe is not changing fundamentally. In this 
regard, large firms seem to matter more (small 
firms' growth appears relevant only in some 
high-tech sectors). 
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The main results of the scenario analyses 
can be summarized as follows: 
a)  The simulated scenarios suggest that 
corporate R&D spending of the EU 
Industrial R&D Investment Scoreboard 
listed companies will rise by a total of 
70 - 90% until 2020 in comparison to 
the figures from SB-2010 (depending 
on the assumed scenario and subject to 
a series of assumptions). 
b)  The ratio of Business Enterprise 
Expenditure on R&D [BERD]/GDP in EU-
27 is expected to increase to 1.6 - 2.0% 
by 2020 and may thus reach the Europe 
2020 target in this regard (3% GERD, of 
which 2/3 should come from the 
business sector), if both the most 
optimistic firm growth scenario and the 
lowest assumed GDP growth projections 
are realised. 
c)  The share of high-R&D-intensive sectors 
in terms of total expenditure on R&D in 
Europe is forecast to increase from 34% 
in SB-2010 to at least 37% (low-growth 
scenario) and possibly 43% in the 
highest-growth scenario. In turn, shares 
of low- and medium-low-R&D intensive 
sectors are expected to remain virtually 
unchanged.  
As the simulated scenarios vary according 
to the assumptions concerning small firms' 
growth, the magnitude of the differences in 
the results provides a good indication of the 
importance of small vs. large firms for 
certain sectors.  
Overall, the projection indicates that, if one 
expects the present small R&D-intensive 
firms to be an engine for a substantial 
structural change in the European economy, 
from being driven by medium-tech sectors 
towards a high-tech-based economy, this 
requires either a significantly longer 
timescale for the assumed fast growth track 
than the simulated 10 years, or that small 
firms' growth figures exceed the assumed 
annual 30% (as in the most optimistic 
scenario). Neither eventuality appears to be 
particularly realistic. 
 
4. Policy implications 
This article aims to illustrate the capacity of 
the current population of top innovative 
SMEs to drive the necessary structural shift 
of the European economy towards more 
knowledge-intensive sectors. Though relying 
on strong assumptions and a 
methodologically rather simple linear 
projection, the results help to put into 
perspective the level of ambition of the EU 
R&D intensity target and contribute to the 
debate on where the EU research and 
innovation policy agenda should place the 
emphasis to reach its objectives.  
In sum, the scenario simulations have 
revealed that - by relying especially on the 
existing population of R&D-intensive SMEs - 
the EU will probably not manage to 
accelerate sufficiently the renewal of the 
economic structure towards knowledge-
intensive sectors and thus achieve the 
objective set out for the year 2020. In fact, 
even in the most optimistic scenario 
hypothesised the EU will hardly change its 
industrial structure (i.e. high-tech sectors 
will still contribute 43% of the total private 
R&D investment in 2020, from a share of 
34% in 2010), which will continue to be 
substantially different from its US 
counterpart (in which, for example, high-
tech sectors contribute 68% of the total 
private R&D investment already in 2010). 
This comparatively slow rate anticipated 
with regard to the shift of the EU’s sector 
composition hinders the efforts made to 
close the gap of private R&D investment 
between the EU and its main competitors.7. 
Hence, it can be concluded that to 
accelerate the renewal of the industrial 
structure in the EU, besides stimulating a 
more frequent creation of innovative firms 
and facilitating SMEs to tap into R&D 
activities, we will also need an increase in 
R&D activities performed by large-scale 
corporations (i.e., increase volume and R&D 
intensity, by generating and/or absorbing 
more R&D and innovation also in less 
technological intensive sectors, and diversify 
sector of business activities towards more 
knowledge-intense ones). This illustrates the 
importance of stimulating the creation of 
new technology-based firms, the growth of 
both smaller and large innovative 
companies and the need to promote the 
coexistence of innovative and competitive 
firms of different sizes which may follow 
different growth paths.  
                                                        
7 See Moncada-Paternò-Castello et al.., 2010 ‣ on the EU-US 
corporate R&D investment gap 
7  
 
Overall, there is also need of increasing R&D 
investment volumes in less technological 
intensive sectors, promoting their R&D 
absorptive capacity and their diversification 
towards more knowledge-intensive 
activities.  
In this respect, the EU research and 
innovation policy agenda needs to find the 
right policies and instruments to support the 
growth of the whole range of innovative 
 
 
 
 
companies, covering a large spectrum of 
options8 from framework conditions to fim- 
level incentives. This implies the need for 
differentiated policy instruments targeting 
different firm classes (by size, age, business 
model, industry, etc.) and sectors (from high 
R&D to low R&D-intensive ones). In addition, 
measures to support new high-tech 
ventures and their rapid growth are of the 
utmost importance. 
 
 
 
 
 
 
                                                        
8  Policies to foster private R&D and innovation address 
following fields: a) framework and market conditions (e.g. 
infrastructures, economic stability, internal market rules, 
the labour market, the financial market for innovation, 
innovation demand, entrepreneurial culture, etc.), b) Factor 
endowment/capability: appropriate governance and 
management of science/technology-based business, 
knowledge/skills, absorptive capacity, c) Individual and 
social incentives.  
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ANNEX 
 
I. More on the relevance of SMEs vs large firms in the EU 
The 20.7 million SMEs represent more than 98% of all businesses in the EU and hold 67% 
of the total employment in the EU (EC, 2012).9 On the other hand, in most EU countries 
large-size enterprises account for a considerable part of the value added of the business 
sector despite representing a comparably very small share of the total population of 
businesses (OECD, 2012).10 Moreover, the share of business enterprise expenditures on R&D 
(BERD) in terms of Gross Value Added (GVA) of EU large-size enterprises is about five times 
as high as that of SMEs (EC, 2013).11  
 
II. R&D investment shares by sector group in the US in 2010 
For possible comparison with the information on EU-27 presented in Figure 1, Figure A1 
below reports R&D investment shares by sector group in the US in 2010. 
 
Figure A1 - R&D investment shares by sector group in US in 2010 
 
 
 
 
 
 
 
 
 
   Legend: Black: high-tech. Dark grey: medium-high tech. Lighter grey: medium-low tech. White: low-tech 
   Source: The 2010 EU Industrial R&D Investment Scoreboard (European Commission, JRC/DG RTD, 2011 ‣). 
 
 
III. More information about the scenario building 
Reference scenario (RS): All firms may grow at the same growth rate of 7.1% (unweighted 
average 8 years’ employment CAGR across all EU SB firms) regardless of the corresponding 
company size. This reference scenario corresponds to a simple extrapolation of the status 
quo average growth paths (i.e. a continuation of the 2002-2009 growth trajectory until 
2020).12  
 
 
                                                        
9  European Commission (2013) EU SMEs in 2012: at the crossroads. Annual report on small and medium-sized enterprises in the EU, 
2011/2012. ECORYS, Rotterdam, September 2012.    
10  OECD (2012), Entrepreneurship at a Glance 2012, OECD Publishing - doi: 10.1787/entrepreneur_aag-2012-en 
11  European Commission (2013). Share of Business enterprise expenditures on R&D (BERD) to the gross value added (GVA) – 
Unpublished calculations by DG Research and Innovation/Economic Analysis Unit based on OECD, Eurostat and DG Enterprise and 
Industry.                                                                     
12  Employment CAGR 8yrs across all 2,000 SB firms: 6.1% (only EU: 7.1%); large-scale firms in EU: 5.8%, in RoW: 4.8% (all large firms 
together: 5.3%); SMEs in EU: 15.0%, SMEs in RoW: 12.6% (all: 14.6%). 
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Target Scenario (A): R&D-intensive SMEs in the SB grow 10% per year until 2020. Note: 
The average annual employment growth rate calculated for the corresponding sample 
of firms for the period 2002 – 2009 was 15% (i.e. this scenario is rather ‘pessimistic’ as it 
assumes a decline in small firms’ average growth patterns). Firms other than SMEs are 
assumed to grow 5.8% per year until 2020, which represents the average 8-year 
employment CAGR for all firms which have not been classified as SMEs at any point 
between 2002 and 2009. 
Target Scenario (B): 20% annual growth rate for SMEs: Implicitly this scenario corresponds 
to the definition of a fast growing firm as agreed by OECD and EUROSTAT: A company is 
thus classified as being 'fast growing' if, in a consecutive three-year period, in each of these 
years a minimum of 20% increase in either sales or employment is achieved.13 All other SB 
firms (non-SMEs) are assumed to grow 5.8% per year until 2020. 
Target Scenario (C): 30% annual growth rate for SMEs, while all other firms in the SB grow 
5.8% per year until 2020 (equal to the average over the previous years). 
Please note that all company data have been adjusted for both inflation and exchange rate 
effects14, i.e. all figures are converted into values corresponding to 2010 prices in Euros. 
Accordingly, all presented scenario results are directly comparable (no further adjustment or 
discounting needed). 
 
IV. More information about the results of the scenario projections 
Table A1 below provides volumes and shares for both the SB 2010 and the scenarios by sector group in 
terms of R&D intensity. 
 
Table A1 - Results of scenario projections by sector – R&D investment (€) 
 
 
 
SB 2010 
 
 
R-S 
SB 2020 
reference 
scenario (all 
firm sizes + 
7.1% p.a.) 
SB 2020 
Scenario A 
(SMEs +10% 
p.a.) 
SB 2020 
Scenario B 
(SMEs +20% 
p.a.) 
SB 2020 
Scenario C 
(SMEs +30% 
p.a.) 
R&D investment by SB companies 
from EU (€billion/million) 128bn % 227bn % 220bn % 228bn % 244bn % 
Pharma & Biotech 20397 15.9 36308 16.0 41086 18.6 46133 20.2 56785 23.3 
ICT related 19070 14.9 33488 14.8 32485 14.7 34441 15.1 38571 15.8 
Other high-tech 3970 3.1 6987 3.1 8100 3.7 8337 3.7 8839 3.6 
Automobile & parts 27408 21.4 55185 24.3 41030 18.6 41043 18.0 41070 16.8 
Electronic & Electricals  6994 5.5 12528 5.5 9960 4.5 10064 4.4 10283 4.2 
Chemicals 7473 5.8 13595 6.0 11532 5.2 11544 5.1 11569 4.7 
Aerospace & Defence 7998 6.2 14668 6.5 16000 7.2 16044 7.0 16136 6.6 
Other medium-high 12073 9.4 19671 8.7 19093 8.6 19226 8.4 19508 8.0 
Medium-low-tech  9487 7.4 14689 6.5 14328 6.5 14349 6.3 14396 5.9 
Low-tech 13106 10.2 20274 8.9 26918 12.2 26927 11.8 26946 11.0 
Note: Following the OECD approach (2005), sectors are split into four groups according to the R&D intensity: 
- High-tech: R&D intensity (R&D/sales) above 5% 
- Medium-high tech: R&D intensity (R&D/sales) between 2% and 5% 
- Medium-low tech: R&D intensity (R&D/sales) between 1% and 2% 
- Low-tech: R&D intensity sector group: below 5%. 
For details see European Commission: The 2010 EU Industrial R&D Investment Scoreboard.  
 
 
 
                                                        
13   See: OECD-EUROSTAT (2005). 
14  For more details, see pages 9-11 of the corresponding study (Voigt and Moncada-Paternò-Castello, 2012‣) 
http://iri.jrc.ec.europa.eu/documents/10180/12134/Projection%20of%20R%26D%20Intensive%20Enterprises%27%20Growth%20to
%20the%20year%202020%20-%20Implications%20for%20EU%20policy 
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Abstract 
The Policy Brief addresses the following question:  To what extent the high-growth of current innovative R&D-intensive SMEs can drive the 
envisaged structural change of the EU economy towards high R&D intensive sectors?  It aims to contribute to the debate about how to set 
the right priorities and find the most appropriate policy interventions to allow Europe to reach the 3% R&D intensity target and hence its 
growth and employment objectives. It first summarises stylised findings from the literature on the relevance of innovative companies for 
economic growth, then presents results from a recent JRC-IPTS study which go some way towards answering the question posed above, 
and concludes by outlining some of the contributions that enrich the policy debate. 
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